# BioNexus Gene Lab Corp: Form 8-K, filed Jan 2, 2025

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: 8-K
- Filed: 2025-01-02
- Accepted by EDGAR: Jan 2, 2025, 15:30 ET
- Period: 2024-12-27
- Accession: 0001477932-25-000006
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000147793225000006/bglc_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000147793225000006/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000147793225000006/bglc_8k.htm

Filed Jan 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001477932-25-000006. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.